Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Adoport 1mg capsules
0802020T0BEAAAB
|
Adoport | Tacrolimus | Malignant Disease and Immunosuppression | 5,878 |
|
Tamoxifen 10mg tablets
0803041S0AAAAAA
|
Tamoxifen citrate | Tamoxifen citrate | Malignant Disease and Immunosuppression | 4,896 |
|
Neoral 50mg capsules
0802020G0BCACAF
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 4,639 |
|
Leuprorelin 3.75mg inj pre-filled syringes
0803042N0AAACAC
|
Leuprorelin acetate | Leuprorelin acetate | Malignant Disease and Immunosuppression | 4,442 |
|
Prograf 500microgram capsules
0802020T0BBADAF
|
Prograf | Tacrolimus | Malignant Disease and Immunosuppression | 3,805 |
|
Neoral 25mg capsules
0802020G0BCABAC
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 3,529 |
|
Adoport 0.5mg capsules
0802020T0BEACAF
|
Adoport | Tacrolimus | Malignant Disease and Immunosuppression | 3,375 |
|
Nordimet 20mg/0.8ml solution for injection pre-filled pens
0801030P0BFAFFS
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 3,207 |
|
Triptorelin 11.25mg inj vials
0803042W0AAAAAA
|
Triptorelin | Triptorelin | Malignant Disease and Immunosuppression | 2,670 |
|
Advagraf 1mg modified-release capsules
0802020T0BCABAN
|
Advagraf | Tacrolimus | Malignant Disease and Immunosuppression | 2,514 |
|
Nordimet 15mg/0.6ml solution for injection pre-filled pens
0801030P0BFADFQ
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 2,491 |
|
CellCept 500mg tablets
0802010M0BBABAB
|
CellCept | Mycophenolate mofetil | Malignant Disease and Immunosuppression | 2,413 |
|
Neoral 100mg capsules
0802020G0BCADAD
|
Neoral | Ciclosporin | Malignant Disease and Immunosuppression | 2,318 |
|
Adoport 2mg capsules
0802020T0BEAEBG
|
Adoport | Tacrolimus | Malignant Disease and Immunosuppression | 2,032 |
|
Nordimet 25mg/1ml solution for injection pre-filled pens
0801030P0BFAHFU
|
Nordimet | Methotrexate | Malignant Disease and Immunosuppression | 1,773 |
|
Medroxyprogesterone 200mg tablets
0803020H0AAADAD
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 1,690 |
|
Medroxyprogesterone 100mg tablets
0803020H0AAACAC
|
Medroxyprogest acetate (Cancer) | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | 1,530 |
|
Azathioprine 100mg tablets
0802010G0AACNCN
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 1,529 |
|
Arimidex 1mg tablets
0803041B0BBAAAA
|
Arimidex | Anastrozole | Malignant Disease and Immunosuppression | 1,506 |
|
Imuran 50mg tablets
0802010G0BCABAE
|
Imuran | Azathioprine | Malignant Disease and Immunosuppression | 1,489 |
|
Femara 2.5mg tablets
0803041L0BBAAAA
|
Femara | Letrozole | Malignant Disease and Immunosuppression | 1,478 |
|
Megestrol 160mg tablets
0803020L0AAABAB
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | 1,337 |
|
Cyproterone 100mg tablets
0803042E0AAABAB
|
Cyprote acetate (Prostate) | Cyproterone acetate | Malignant Disease and Immunosuppression | 1,308 |
|
Advagraf 3mg modified-release capsules
0802020T0BCADAT
|
Advagraf | Tacrolimus | Malignant Disease and Immunosuppression | 1,137 |
|
Diethylstilbestrol 1mg tablets
0803010K0AAAKAK
|
Diethylstilbestrol (Systemic) | Diethylstilbestrol | Malignant Disease and Immunosuppression | 1,009 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.